The brain is central to every aspect of our lives, yet it isn’t monitored with the same consistency and proactivity as other vital signs. As a neuroscience technology company, we believe that better brain health insights lead to better brain health outcomes. That's why we're on a mission to democratize cognitive health by radically simplifying the way it is measured.
For more than 20 years, we’ve proudly supported the research needs of biopharmaceutical companies and academic institutions, and the clinical care needs of physicians and individuals around the world. We create easy to use digital tests that provide rapid, reliable, and science-backed results and offer solutions that support the highest fidelity measurements possible.
We believe our team members should have flexibility as to how, when, and where they work. We work flexibly to support our global team, who mostly work from home––and offer opportunities for face-to-face collaboration at our offices in New Haven, Melbourne, and London. Our team members also have access to co-working spaces around the world.
Cognito Therapeutics is a pioneer in non-invasive neuromodulation to treat neurodegenerative diseases and improve human cognitive performance. The company has completed multiple clinical studies demonstrating its investigational therapeutic has the potential to safely slow or stop cognitive decline and loss of brain volume in Alzheimer’s disease.
Cognito has received FDA Breakthrough Device Designation for the treatment of Alzheimer’s disease and expects to start pivotal studies in 2022. The company’s technology was based on pioneering optogenetics research by scientific co-founders Professors Li-Huei Tsai and Ed Boyden at MIT.
Welcome to Akili!
At Akili, we believe there is potential for medicine to be developed, delivered and experienced in a completely different way.
We’re bringing together world-class neuroscience with exceptional creativity and video game development to challenge the status quo of medicine. Our digital medicine is not delivered through a pill, but rather through a patented and captivating video game experience. Effective medicine that’s captivating and enjoyable to use – now that’s refreshing!
We're continuously evaluating new technologies and are advancing a broad pipeline of programs to treat cognitive deficiency and improve symptoms associated with medical conditions across neurology and psychiatry, including attention-deficit hyperactivity/ disorder (ADHD), major depressive disorder (MDD), autism spectrum disorder (ASD) and various inflammatory diseases.
And we're always looking for game-changers to join our team – to help us change the status quo of medicine and ignite new hope for those living with cognitive deficits.
Imagine what medicine can be®